BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Compston A. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509. Brain 2009;132:1997-2001. [PMID: 19634211 DOI: 10.1093/brain/awp193] [Cited by in Crossref: 36] [Cited by in F6Publishing: 104] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kumar MK, Kumar V, Singh PK. Wilson's Disease with Neurological Presentation, without Hepatic Involvement in Two Siblings. J Clin Diagn Res 2013;7:1476-8. [PMID: 23998100 DOI: 10.7860/JCDR/2013/5974.3188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Pierson H, Yang H, Lutsenko S. Copper Transport and Disease: What Can We Learn from Organoids? Annu Rev Nutr 2019;39:75-94. [PMID: 31150593 DOI: 10.1146/annurev-nutr-082018-124242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
3 Lin YC, Chen IH, Yang KC, Wang CC. Unusual neuromuscular presentation of a Wilson's disease patient with one-stage surgical correction treatment: A case report. J Orthop Surg (Hong Kong) 2020;28:2309499020934053. [PMID: 32597307 DOI: 10.1177/2309499020934053] [Reference Citation Analysis]
4 Yi F, Qu J, Li M, Suzuki K, Kim NY, Liu GH, Belmonte JC. Establishment of hepatic and neural differentiation platforms of Wilson's disease specific induced pluripotent stem cells. Protein Cell 2012;3:855-63. [PMID: 22806248 DOI: 10.1007/s13238-012-2064-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
5 Prashanth L, Sinha S, Taly A, A.mahadevan, Vasudev M, Shankar S. Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates. Journal of the Neurological Sciences 2010;291:44-51. [DOI: 10.1016/j.jns.2010.01.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
6 Chakor RT, Santhosh NS. Severe neuropsychiatric presentation of Wilson's disease. Indian J Psychiatry 2011;53:170-1. [PMID: 21772656 DOI: 10.4103/0019-5545.82556] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Shah B, Limbu S. A Case Report of Misdiagnosis of Psychotic Symptoms Predominant Wilson's Disease. J Neurosci Rural Pract 2018;9:616-8. [PMID: 30271060 DOI: 10.4103/jnrp.jnrp_515_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dastsooz H, Dehghani SM, Imanieh MH, Haghighat M, Moini M, Fardaei M. A new ATP7B gene mutation with severe condition in two unrelated Iranian families with Wilson disease. Gene 2013;514:48-53. [PMID: 23159873 DOI: 10.1016/j.gene.2012.10.085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Cocoş R, Şendroiu A, Schipor S, Bohîlţea LC, Şendroiu I, Raicu F. Genotype-phenotype correlations in a mountain population community with high prevalence of Wilson's disease: genetic and clinical homogeneity. PLoS One 2014;9:e98520. [PMID: 24897373 DOI: 10.1371/journal.pone.0098520] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
10 Dalvi A. Wilson's disease: neurological and psychiatric manifestations. Dis Mon 2014;60:460-4. [PMID: 25234179 DOI: 10.1016/j.disamonth.2014.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Aggarwal A, Bhatt M. Advances in Treatment of Wilson Disease. Tremor Other Hyperkinet Mov (N Y) 2018;8:525. [PMID: 29520330 DOI: 10.7916/D841881D] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
12 Litwin T, Dusek P, Szafrański T, Dzieżyc K, Członkowska A, Rybakowski JK. Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment. Ther Adv Psychopharmacol 2018;8:199-211. [PMID: 29977520 DOI: 10.1177/2045125318759461] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 12.7] [Reference Citation Analysis]
13 Sahoo MK, Avasthi A, Sahoo M, Modi M, Biswas P. Psychiatric manifestations of Wilson's disease and treatment with electroconvulsive therapy. Indian J Psychiatry 2010;52:66-8. [PMID: 20174521 DOI: 10.4103/0019-5545.58898] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
14 Amano T, Matsubara T, Nishida T, Shimakoshi H, Shimoda A, Sugimoto A, Takahashi K, Mukai K, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M. Clinically diagnosed late-onset fulminant Wilson’s disease without cirrhosis: A case report. World J Gastroenterol 2018; 24(2): 290-296 [PMID: 29375214 DOI: 10.3748/wjg.v24.i2.290] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
15 Xu R, Liang J, Cheng M, Wu H, Wu H, Cao S, Zhao W, Xu R, Zhou A. Liver and urine metabolomics reveal the protective effect of Gandou decoction in copper-laden Hepatolenticular degeneration model rats. J Chromatogr B Analyt Technol Biomed Life Sci 2021;1179:122844. [PMID: 34246170 DOI: 10.1016/j.jchromb.2021.122844] [Reference Citation Analysis]
16 Wang H, Zhou Z, Hu J, Han Y, Wang X, Cheng N, Wu Y, Yang R. Renal impairment in different phenotypes of Wilson disease. Neurol Sci 2015;36:2111-5. [PMID: 26219584 DOI: 10.1007/s10072-015-2322-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong MR, Obeso JA. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci 2010;11:760-72. [PMID: 20944662 DOI: 10.1038/nrn2915] [Cited by in Crossref: 556] [Cited by in F6Publishing: 520] [Article Influence: 50.5] [Reference Citation Analysis]
18 Zhou ZH, Wu YF, Yan Y, Liu AQ, Yu QY, Peng ZX, Wang GQ, Hong MF. Persistence with medical treatment for Wilson disease in China based on a single center's survey research. Brain Behav 2021;11:e02168. [PMID: 33949793 DOI: 10.1002/brb3.2168] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Cai S, Gong JY, Yang J, Wang JS. Anemia following zinc treatment for Wilson's disease: a case report and literature review. BMC Gastroenterol 2019;19:120. [PMID: 31288754 DOI: 10.1186/s12876-019-1038-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Lutsenko S, Gupta A, Burkhead JL, Zuzel V. Cellular multitasking: the dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance. Arch Biochem Biophys 2008;476:22-32. [PMID: 18534184 DOI: 10.1016/j.abb.2008.05.005] [Cited by in Crossref: 149] [Cited by in F6Publishing: 138] [Article Influence: 11.5] [Reference Citation Analysis]
21 Guerrero-Jiménez M, Carrillo de Albornoz Calahorro CM, Gutierrez Rojas L. Wilson disease and psychiatric symptoms: A brief case report. Gen Psychiatr 2019;32:e100066. [PMID: 31423476 DOI: 10.1136/gpsych-2019-100066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Piñero J, Queralt-Rosinach N, Bravo À, Deu-Pons J, Bauer-Mehren A, Baron M, Sanz F, Furlong LI. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database (Oxford) 2015;2015:bav028. [PMID: 25877637 DOI: 10.1093/database/bav028] [Cited by in Crossref: 446] [Cited by in F6Publishing: 365] [Article Influence: 74.3] [Reference Citation Analysis]
23 Salari M, Fayyazi E, Mirmosayyeb O. Magnetic resonance imaging findings in diagnosis and prognosis of Wilson disease. J Res Med Sci 2018;23:23. [PMID: 29692820 DOI: 10.4103/jrms.JRMS_362_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Lörinczi E, Tsivkovskii R, Haase W, Bamberg E, Lutsenko S, Friedrich T. Delivery of the Cu-transporting ATPase ATP7B to the plasma membrane in Xenopus oocytes. Biochim Biophys Acta 2008;1778:896-906. [PMID: 18222167 DOI: 10.1016/j.bbamem.2007.12.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
25 Koboldt DC, Hickey SE, Chaudhari BP, Mihalic Mosher T, Bedrosian T, Crist E, Kaler SG, McBride K, White P, Wilson RK. Early-onset Wilson disease caused by ATP7B exon skipping associated with intronic variant. Cold Spring Harb Mol Case Stud 2020;6:a005306. [PMID: 32532881 DOI: 10.1101/mcs.a005306] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Pandyan DA, Giri GVV, Shanthi K, Suthanraj AK, Kumar S. Copper extraction: Dental consideration for Wilson's disease - An uncommon case report. Natl J Maxillofac Surg 2019;10:235-7. [PMID: 31798263 DOI: 10.4103/njms.NJMS_60_18] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Frota NAF, Caramelli P, Barbosa ER. Cognitive impairment in Wilson's disease. Dement Neuropsychol 2009;3:16-21. [PMID: 29213604 DOI: 10.1590/S1980-57642009DN30100004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
28 Gupta A, Chattopadhyay I, Dey S, Nasipuri P, Das SK, Gangopadhyay PK, Ray K. Molecular pathogenesis of Wilson disease among Indians: a perspective on mutation spectrum in ATP7B gene, prevalent defects, clinical heterogeneity and implication towards diagnosis. Cell Mol Neurobiol 2007;27:1023-33. [PMID: 17823867 DOI: 10.1007/s10571-007-9192-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
29 Mufti AR, Reau N. Liver disease in pregnancy. Clin Liver Dis 2012;16:247-69. [PMID: 22541697 DOI: 10.1016/j.cld.2012.03.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
30 Hibar DP, Stein JL, Ryles AB, Kohannim O, Jahanshad N, Medland SE, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Saykin AJ, Jack CR Jr, Weiner MW, Toga AW, Thompson PM; Alzheimer’s Disease Neuroimaging Initiative. Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjects. Brain Imaging Behav 2013;7:102-15. [PMID: 22903471 DOI: 10.1007/s11682-012-9199-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
31 Mohr I, Weiss KH. Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease. Clin Biochem Rev 2019;40:59-77. [PMID: 31205375 DOI: 10.33176/AACB-18-00014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
32 Sener RN. The claustrum on MRI: normal anatomy, and the bright claustrum as a new sign in Wilson's disease. Pediatr Radiol 1993;23:594-6. [PMID: 8152872 DOI: 10.1007/BF02014975] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
33 Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab Brain Dis 2004;19:229-39. [PMID: 15554419 DOI: 10.1023/b:mebr.0000043973.10494.85] [Cited by in Crossref: 76] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
34 Aggarwal A, Bhatt M. The Pragmatic Treatment of Wilson's Disease. Mov Disord Clin Pract 2014;1:14-23. [PMID: 30363895 DOI: 10.1002/mdc3.12003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
35 Didonna A, Opal P. Advances in Sequencing Technologies for Understanding Hereditary Ataxias: A Review. JAMA Neurol 2016;73:1485-90. [PMID: 27749953 DOI: 10.1001/jamaneurol.2016.3097] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
36 Torgerson CM, Van Horn JD. A case study in connectomics: the history, mapping, and connectivity of the claustrum. Front Neuroinform 2014;8:83. [PMID: 25426062 DOI: 10.3389/fninf.2014.00083] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
37 Xu P, Lu ZL, Wang X, Dosher B, Zhou J, Zhang D, Zhou Y. Category and perceptual learning in subjects with treated Wilson's disease. PLoS One 2010;5:e9635. [PMID: 20224790 DOI: 10.1371/journal.pone.0009635] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
38 Fujiyoshi J, Yamaza H, Sonoda S, Yuniartha R, Ihara K, Nonaka K, Taguchi T, Ohga S, Yamaza T. Therapeutic potential of hepatocyte-like-cells converted from stem cells from human exfoliated deciduous teeth in fulminant Wilson's disease. Sci Rep 2019;9:1535. [PMID: 30733544 DOI: 10.1038/s41598-018-38275-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
39 Li H, Tao R, Liu L, Shang S. Population screening and diagnostic strategies in screening family members of Wilson's disease patients. Ann Transl Med. 2019;7:S59. [PMID: 31179296 DOI: 10.21037/atm.2019.03.54] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Purchase R. The Treatment of Wilson's Disease, a Rare Genetic Disorder of Copper Metabolism. Science Progress 2013;96:19-32. [DOI: 10.3184/003685013x13587771579987] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
41 Wijayasiri P, Hayre J, Nicholson ES, Kaye P, Wilkes EA, Evans J, Aithal GP, Jones G, Pearce F, Aravinthan AD. Estimating the clinical prevalence of Wilson's disease in the UK. JHEP Rep 2021;3:100329. [PMID: 34381985 DOI: 10.1016/j.jhepr.2021.100329] [Reference Citation Analysis]
42 Glajch KE, Kelver DA, Hegeman DJ, Cui Q, Xenias HS, Augustine EC, Hernández VM, Verma N, Huang TY, Luo M, Justice NJ, Chan CS. Npas1+ Pallidal Neurons Target Striatal Projection Neurons. J Neurosci 2016;36:5472-88. [PMID: 27194328 DOI: 10.1523/JNEUROSCI.1720-15.2016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 11.8] [Reference Citation Analysis]
43 Cao C, Colangelo T, Dhanekula RK, Brandt D, Laothamatas I, Thapar M, Herrine SK, Civan JM. A Rare Case of Wilson Disease in a 72-Year-Old Patient. ACG Case Rep J 2019;6:1-3. [PMID: 31620489 DOI: 10.14309/crj.0000000000000024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Bhatnagar N, Lingaiah P, Lodhi JS, Karkhur Y. Pathological Fracture of Femoral Neck Leading to a Diagnosis of Wilson's Disease: A Case Report and Review of Literature. J Bone Metab 2017;24:135-9. [PMID: 28642858 DOI: 10.11005/jbm.2017.24.2.135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Lopez Morra HA, Debes JD, Dickstein G. Wilson's disease: what lies beneath. Dig Dis Sci 2007;52:941-2. [PMID: 17333351 DOI: 10.1007/s10620-006-9463-z] [Reference Citation Analysis]
46 Peng F. Positron emission tomography for measurement of copper fluxes in live organisms. Ann N Y Acad Sci. 2014;1314:24-31. [PMID: 24628290 DOI: 10.1111/nyas.12383] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
47 Zischka H, Lichtmannegger J, Schmitt S, Jägemann N, Schulz S, Wartini D, Jennen L, Rust C, Larochette N, Galluzzi L, Chajes V, Bandow N, Gilles VS, DiSpirito AA, Esposito I, Goettlicher M, Summer KH, Kroemer G. Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease. J Clin Invest 2011;121:1508-18. [PMID: 21364284 DOI: 10.1172/JCI45401] [Cited by in Crossref: 105] [Cited by in F6Publishing: 55] [Article Influence: 10.5] [Reference Citation Analysis]
48 Cheng M, Wu H, Wu H, Liu X, Zhou A. Metabolic profiling of copper-laden hepatolenticular degeneration model rats and the interventional effects of Gandou decoction using UPLC-Q-TOF/MS. J Pharm Biomed Anal 2019;164:187-95. [PMID: 30390561 DOI: 10.1016/j.jpba.2018.10.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
49 Hermann W, Huster D. [Diagnostics of Wilson's disease]. Nervenarzt 2018;89:115-23. [PMID: 29159549 DOI: 10.1007/s00115-017-0452-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
50 Shribman S, Warner TT, Dooley JS. Clinical presentations of Wilson disease. Ann Transl Med. 2019;7:S60. [PMID: 31179297 DOI: 10.21037/atm.2019.04.27] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
51 Chen Y, Zhang B, Cao S, Huang W, Liu N, Yang W. GanDouLing combined with Penicillamine improves cerebrovascular injury via PERK/eIF2α/CHOP endoplasmic reticulum stress pathway in the mouse model of Wilson's disease. Biosci Rep 2018;38:BSR20180800. [PMID: 30181379 DOI: 10.1042/BSR20180800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
52 Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC. Wilson’s disease: A review of what we have learned. World J Hepatol 2015; 7(29): 2859-2870 [PMID: 26692151 DOI: 10.4254/wjh.v7.i29.2859] [Cited by in Crossref: 78] [Cited by in F6Publishing: 49] [Article Influence: 13.0] [Reference Citation Analysis]
53 Li K, Zhang WM, Lin S, Wen L, Wang ZF, Xie D, Wei M, Qiu ZQ, Dai Y, Lin MC. Mutational analysis of ATP7B in north Chinese patients with Wilson disease. J Hum Genet. 2013;58:67-72. [PMID: 23235335 DOI: 10.1038/jhg.2012.134] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
54 Kaler SG. Microbial peptide de-coppers mitochondria: implications for Wilson disease. J Clin Invest 2016;126:2412-4. [PMID: 27322063 DOI: 10.1172/JCI88617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Daneshjoo O, Garshasbi M. Novel compound heterozygote mutations in the ATP7B gene in an Iranian family with Wilson disease: a case report. J Med Case Rep 2018;12:68. [PMID: 29540233 DOI: 10.1186/s13256-018-1608-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
56 Xiao Z, Yang Y, Huang H, Tang H, Liu L, Tang J, Shi X. Molecular analysis of 53 Chinese families with Wilson's disease: Six novel mutations identified. Mol Genet Genomic Med 2021;:e1735. [PMID: 34324271 DOI: 10.1002/mgg3.1735] [Reference Citation Analysis]
57 Pereira EA, Aziz TZ. Parkinson's disease and primate research: past, present, and future. Postgrad Med J 2006;82:293-9. [PMID: 16679465 DOI: 10.1136/pgmj.2005.041194] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
58 Azbukina NV, Lopachev AV, Chistyakov DV, Goriainov SV, Astakhova AA, Poleshuk VV, Kazanskaya RB, Fedorova TN, Sergeeva MG. Oxylipin Profiles in Plasma of Patients with Wilson's Disease. Metabolites 2020;10:E222. [PMID: 32485807 DOI: 10.3390/metabo10060222] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Wu F, Wang J, Pu C, Qiao L, Jiang C. Wilson's disease: a comprehensive review of the molecular mechanisms. Int J Mol Sci. 2015;16:6419-6431. [PMID: 25803104 DOI: 10.3390/ijms16036419] [Cited by in Crossref: 59] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
60 Efe SC, Gurbuz AS, Ozturk S, Demir K. Strain and strain rate echocardiography variables in adult Wilson's disease patients: A speckle tracking echocardiography study. J Clin Ultrasound 2020;48:324-9. [DOI: 10.1002/jcu.22849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Sasaki N, Hayashizaki Y, Kasai N. Absence of linkage between the retinoblastoma gene and hts gene in the LEC rat: a model of human Wilson's disease. Jpn J Cancer Res 1993;84:1019-22. [PMID: 8226276 DOI: 10.1111/j.1349-7006.1993.tb02795.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Seo JK. Diagnosis of Wilson disease in young children: molecular genetic testing and a paradigm shift from the laboratory diagnosis. Pediatr Gastroenterol Hepatol Nutr 2012;15:197-209. [PMID: 24010089 DOI: 10.5223/pghn.2012.15.4.197] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
63 Vaishnav P, Gandhi HA. Electro Convulsive Therapy in Psychiatric Manifestations in Wilson's Disease. Indian J Psychol Med 2013;35:206-8. [PMID: 24049234 DOI: 10.4103/0253-7176.116257] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
64 Gupta A. Low-density oligonucleotide microarrays - A major step in Wilson's disease diagnosis. Indian J Med Res 2015;141:145-7. [PMID: 25900946 DOI: 10.4103/0971-5916.155534] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
65 Dastsooz H, Imanieh MH, Dehghani SM, Haghighat M, Moini M, Fardaei M. Multiplex ARMS PCR to Detect 8 Common Mutations of ATP7B Gene in Patients With Wilson Disease. Hepat Mon. 2013;13:e8375. [PMID: 24003324 DOI: 10.5812/hepatmon.8375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
66 Hu S, Wu H, Xu C, Wang A, Wang Y, Shen T, Huang F, Kan H, Li C. Aberrant Coupling Between Resting-State Cerebral Blood Flow and Functional Connectivity in Wilson's Disease. Front Neural Circuits 2019;13:25. [PMID: 31057370 DOI: 10.3389/fncir.2019.00025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
67 Plotkin JL, Goldberg JA. Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders. Neuroscientist 2019;25:359-79. [PMID: 30379121 DOI: 10.1177/1073858418807887] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
68 Pfeiffenberger J, Kruse C, Mutch P, Harker A, Weiss KH. The steady state pharmacokinetics of trientine in Wilson disease patients. Eur J Clin Pharmacol 2018;74:731-6. [PMID: 29417175 DOI: 10.1007/s00228-018-2424-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
69 Pandit A, Bavdekar A, Bhave S. Wilson's disease. Indian J Pediatr 2002;69:785-91. [PMID: 12420912 DOI: 10.1007/BF02723693] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
70 Poujois A, Woimant F. Challenges in the diagnosis of Wilson disease. Ann Transl Med 2019;7:S67. [PMID: 31179304 DOI: 10.21037/atm.2019.02.10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
71 Ferreira CR, Gahl WA. Disorders of metal metabolism. Transl Sci Rare Dis 2017;2:101-39. [PMID: 29354481 DOI: 10.3233/TRD-170015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
72 Methawasin K, Chonmaitree P, Wongjitrat C, Rattanamongkolgul S, Asawavichienjinda T. Movement Disorders in Non-Wilsonian Cirrhotic Patients: A Report of the Prevalence and Risk Factors from a Study Done in a Medical School in an Agricultural-Based Community. J Mov Disord 2016;9:28-34. [PMID: 26648181 DOI: 10.14802/jmd.15034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
73 Dusek P, Litwin T, Członkowska A. Neurologic impairment in Wilson disease. Ann Transl Med 2019;7:S64. [PMID: 31179301 DOI: 10.21037/atm.2019.02.43] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
74 Hattingen E, Blasel S, Nichtweiss M, Zanella FE, Weidauer S. MR imaging of midbrain pathologies. Clin Neuroradiol. 2010;20:81-97. [PMID: 20532857 DOI: 10.1007/s00062-010-0009-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
75 Noone ML, Kumar VG, Ummer K, Achambat L, Salam KA. Cirrhosis presenting as Parkinsonism. Ann Indian Acad Neurol 2008;11:179-81. [PMID: 19893665 DOI: 10.4103/0972-2327.42938] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
76 Ezquerra M, Compta Y, Marti MJ. Identifying the genetic components underlying the pathophysiology of movement disorders. Appl Clin Genet 2011;4:81-92. [PMID: 23776369 DOI: 10.2147/TACG.S7333] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Rossi M, Farcy N, Starkstein SE, Merello M. Nosology and Phenomenology of Psychosis in Movement Disorders. Mov Disord Clin Pract 2020;7:140-53. [PMID: 32071931 DOI: 10.1002/mdc3.12882] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
78 Broussolle E, Trocello JM, Woimant F, Lachaux A, Quinn N. Samuel Alexander Kinnier Wilson. Wilson's disease, Queen Square and neurology. Rev Neurol (Paris) 2013;169:927-35. [PMID: 24125461 DOI: 10.1016/j.neurol.2013.04.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
79 Ryan A, Nevitt SJ, Tuohy O, Cook P. Biomarkers for diagnosis of Wilson's disease. Cochrane Database Syst Rev 2019;2019. [PMID: 31743430 DOI: 10.1002/14651858.CD012267.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
80 Cheng N, Wang H, Dong J, Pan S, Wang X, Han Y, Han Y, Yang R. Elevated serum brain natriuretic peptide and matrix metalloproteinases 2 and 9 in Wilson's disease. Metab Brain Dis 2015;30:1087-91. [PMID: 26077744 DOI: 10.1007/s11011-015-9685-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
81 Subramanian I, Vanek ZF, Bronstein JM. Diagnosis and treatment of Wilson's disease. Curr Neurol Neurosci Rep 2002;2:317-23. [PMID: 12044251 DOI: 10.1007/s11910-002-0007-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
82 Gupta A, Aikath D, Neogi R, Datta S, Basu K, Maity B, Trivedi R, Ray J, Das SK, Gangopadhyay PK. Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Hum Genet. 2005;118:49-57. [PMID: 16133174 DOI: 10.1007/s00439-005-0007-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]
83 Pujol J, Fenoll R, Macià D, Martínez-Vilavella G, Alvarez-Pedrerol M, Rivas I, Forns J, Deus J, Blanco-Hinojo L, Querol X, Sunyer J. Airborne copper exposure in school environments associated with poorer motor performance and altered basal ganglia. Brain Behav 2016;6:e00467. [PMID: 27134768 DOI: 10.1002/brb3.467] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
84 Kathawala M, Hirschfield GM. Insights into the management of Wilson's disease. Therap Adv Gastroenterol. 2017;10:889-905. [PMID: 29147139 DOI: 10.1177/1756283x17731520] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
85 Butala A, Shepard M, Pontone G. Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics. Handb Clin Neurol 2019;165:83-121. [PMID: 31727232 DOI: 10.1016/B978-0-444-64012-3.00007-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
86 Kozić DB, Petrović I, Svetel M, Pekmezović T, Ragaji A, Kostić VS. Reversible lesions in the brain parenchyma in Wilson's disease confirmed by magnetic resonance imaging: earlier administration of chelating therapy can reduce the damage to the brain. Neural Regen Res 2014;9:1912-6. [PMID: 25558242 DOI: 10.4103/1673-5374.145360] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
87 Patil M, Sheth KA, Krishnamurthy AC, Devarbhavi H. A review and current perspective on Wilson disease. J Clin Exp Hepatol. 2013;3:321-336. [PMID: 25755520 DOI: 10.1016/j.jceh.2013.06.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
88 Bem RS, Muzzillo DA, Deguti MM, Barbosa ER, Werneck LC, Teive HA. Wilson's disease in southern Brazil: a 40-year follow-up study. Clinics (Sao Paulo) 2011;66:411-6. [PMID: 21552664 DOI: 10.1590/s1807-59322011000300008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
89 Moini M, To U, Schilsky ML. Recent advances in Wilson disease. Transl Gastroenterol Hepatol 2021;6:21. [PMID: 33824925 DOI: 10.21037/tgh-2020-02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Reed E, Lutsenko S, Bandmann O. Animal models of Wilson disease. J Neurochem 2018;146:356-73. [PMID: 29473169 DOI: 10.1111/jnc.14323] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
91 Elyasi F. Misidentification of Wilson Disease as Schizophrenia (1998-2013): Case Report and Review. Indian J Psychol Med 2017;39:675-81. [PMID: 29200569 DOI: 10.4103/IJPSYM.IJPSYM_339_16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
92 Sorbello O, Riccio D, Sini M, Carta M, Demelia L. Resolved Psychosis after Liver Transplantation in a Patient with Wilson's Disease. Clin Pract Epidemiol Ment Health 2011;7:182-4. [PMID: 22291850 DOI: 10.2174/1745017901107010182] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
93 Zhang J, Chen H, Bao Y, Xie D, Yang W, Jiang H, Dong T, Han H. System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of GanDouLing for Wilson's Disease. Evid Based Complement Alternat Med 2021;2021:1248920. [PMID: 33564316 DOI: 10.1155/2021/1248920] [Reference Citation Analysis]
94 Bandmann O, Weiss KH, Kaler SG. Wilson's disease and other neurological copper disorders. Lancet Neurol. 2015;14:103-113. [PMID: 25496901 DOI: 10.1016/s1474-4422(14)70190-5] [Cited by in Crossref: 381] [Cited by in F6Publishing: 117] [Article Influence: 63.5] [Reference Citation Analysis]
95 de Bie P, Muller P, Wijmenga C, Klomp LW. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet. 2007;44:673-688. [PMID: 17717039 DOI: 10.1136/jmg.2007.052746] [Cited by in Crossref: 250] [Cited by in F6Publishing: 207] [Article Influence: 17.9] [Reference Citation Analysis]
96 Kim JW, Kim JH, Seo JK, Ko JS, Chang JY, Yang HR, Kang KH. Genetically confirmed Wilson disease in a 9-month old boy with elevations of aminotransferases. World J Hepatol 2013; 5(3): 156-159 [PMID: 23556051 DOI: 10.4254/wjh.v5.i3.156] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
97 Przedborski S. The two-century journey of Parkinson disease research. Nat Rev Neurosci 2017;18:251-9. [PMID: 28303016 DOI: 10.1038/nrn.2017.25] [Cited by in Crossref: 167] [Cited by in F6Publishing: 146] [Article Influence: 41.8] [Reference Citation Analysis]
98 Dalvi A, Padmanaban M. Wilson's disease: etiology, diagnosis, and treatment. Dis Mon. 2014;60:450-459. [PMID: 25234178 DOI: 10.1016/j.disamonth.2014.07.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
99 Muro S, Yasunaka T, Wada N, Morimoto Y, Ikeda F, Shiraha H, Takaki A, Noso K, Iwasaki H, Yamamoto K. A case of Wilson's disease with characteristic laparoscopic findings. Clin J Gastroenterol 2014;7:175-9. [PMID: 26183637 DOI: 10.1007/s12328-014-0465-7] [Reference Citation Analysis]
100 Kodama H, Fujisawa C, Bhadhprasit W. Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment. Curr Drug Metab. 2012;13:237-250. [PMID: 21838703 DOI: 10.2174/138920012799320455] [Cited by in Crossref: 101] [Cited by in F6Publishing: 79] [Article Influence: 11.2] [Reference Citation Analysis]
101 Hermann W. Classification and differential diagnosis of Wilson's disease. Ann Transl Med 2019;7:S63. [PMID: 31179300 DOI: 10.21037/atm.2019.02.07] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
102 Grover S, Sarkar S, Jhanda S, Chawla Y. Psychosis in an adolescent with Wilson's disease: A case report and review of the literature. Indian J Psychiatry 2014;56:395-8. [PMID: 25568485 DOI: 10.4103/0019-5545.146530] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
103 Kawai K, Atarashi Y, Takahara T, Kudo H, Tajiri K, Tokimitsu Y, Nakayama Y, Hirano K, Yata Y, Minemura M, Yasumura S, Onishi Y, Tsukada K, Tsuneyama K, Takano Y, Sugiyama T. Dietary supplement implicated in fulminant hepatic failure in a well-controlled Wilson disease patient. Clin J Gastroenterol 2009;2:119-24. [PMID: 26192177 DOI: 10.1007/s12328-008-0056-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
104 Li Z, Yu X, Shen J, Liang J. Congential scoliosis in Wilson's disease: case report and review of the literature. BMC Surg 2014;14:71. [PMID: 25252715 DOI: 10.1186/1471-2482-14-71] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]